As part of  Temple University's ongoing efforts to respond to COVID-19 and its impact on research activities and available programs and funding for businesses. The Office of the Vice President for Research (OVPR) has issued a number of guidelines to navigate the changing environment. If you are a small business owner, OVPR has collected resources available from the state and federal government to help you keep your business afloat during the pandemic.

View the latest COVID-19-related research information and funding opportunities for the Research Community here.                

View COVID-19 related available programs and funding for small businesses here.

View ongoing Research Funding opportunities here.                 

Notifications to Community

• July 13, 2020 Update on Human Subjects IRB Guidance Related to COVID-19
   
• May 23, 2020 Notice to Temple Research Community – Update on COVID-19 Return to Research Planning Process and Guidelines
• April  07, 2020 Duane Morris COVID-19 Update
• March 27, 2020 Update on Human Subjects IRB Guidance Related to COVID-19
• March 26, 2020 Office of the Vice President for Research 2020 Bridge Research Program
• March 23, 2020 NSF Dear Colleague Letter and RAPID Research on Coronavirus (COVID-19) 
• March 19, 2020 Enhanced Support for COVID-19 Research Efforts
• March 16, 2020 Notice to Temple Research Community - Update on COVID-19 Research Continuity Planning
• March 16, 2020 ULAR and IACUC Communications Related to COVID-19
• March 12, 2020 Human Subjects IRB Guidance Related to COVID-19  
• March 12, 2020 Research Guidance Related to COVID-19

New Opportunities for COVID-19 Research Funding

Emergent Fund (NEW-7.23.2020)

• Fast Grants- second call launched on July 12, 2020
• COVID-19 Grants- Rolling

America Diabetes Association (--Updated 5.26.2020)

• American Diabetes Association COVID-19 and Diabetes Research Call for Applications (CLOSED)

Centers for Disease Control and Prevention (--Updated 6.4.2020)

• ATSDR's Partnership to Promote Local Efforts to Reduce Environmental Exposure-COVID-19 Supplement (CLOSED)
• Building Capacity for National Public Health Institutes (CLOSED)
• Global Health Security Partner Enhancement: Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability (CLOSED)
• Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally (CLOSED)
• Funding for Strengthening Global Field Epidemiology Training Program Network (CLOSED)
• Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health (CLOSED)

Department of Defense (--Updated 5.13.2020)

• BRO-20-NEWTON Newton Award for Transformative Ideas during the COVID-19 Pandemic (CLOSED)
• Request for Information for PPE in response to COVID-19 (CLOSED)

Department of Defense Medical Technology Enterprise Consortium (--Updated 5.27.2020)

• Medical Technology Enterprise Consortium (MTEC)  Wearable Diagnostic for Detection of COVID-19 Infection(CLOSED)
• Potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19) (UPCOMING)
• MTEC-20-09-COVID-19 Treatment MIDRP Development of Treatments for COVID-19 (CLOSED)

Department of Energy

• DOE Launches National Virtual Biotechnology Laboratory (NVBL)-- NEW 5.12.2020
• DOE Resources available for COVID 19 Study (Deadline: Not announced)

Department of Health and Human Services (Updated 10.31.2020)
Biomedical Advanced Research and Developlment Authority

• BAA-18-100-SOL-00003 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) – COVID -19—Due October 31, 2021 (updated)
  • Amendment 17, new AOI: 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
  • Note: Only submissions in support of COVID-19 research are being reviewed at this time. Review of all other topics is paused
• BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement – COVID-19 Topics—Deadline Feb 03, 2023
  • Special Instructions 008 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002
•  Biomedical Advanced Research and Development Authority (BARDA): 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities

Department of Justice (NEW-5.5.2020)

• Funding Resource Center

National Endowment for the Humanties (NEW-5.5.2020)

• NEH CARES: Cultural Organizations (CLOSED)

National Institutes of Health (--Updated 11.16.2020)

• Notice of Special Interest: Availability of Administrative Supplements and Revisions Supplements (CLOSED)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 9COVID-19) and the Causative Virus SARS-CoV-2 (Deadline: February 6, 2021)

  All other active NIH fundings: 

• PAR-20-237 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01-Clinical Trial Optional)-(CLOSED)
• PAR-18-781 Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
• NOT-GM-20-025 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (Deadline: February 6, 2021)
• NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
• NOT-AI-20-030 Notice of Special Interest (NOSI) for Research on the 2019 Novel Coronavirus (2019-nCoV) (CLOSED)
• NOT-HL-20-757 Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (CLOSED)

National Science Foundation (--Updated 4.21.2020)

• Rapid Response Research Proposals (Revised April 3, 2020)
• RAPID Cyber Proposal

Technology Development Funding and Resources (UPDATED--6.4.2020)

• Fast-Grants:  Fast Funding for COVID-19 Science (Applications are paused due to a large number of submissions. Please check here for updates)
• NSF COVID-19 Phase I SBIR/STTR Opportunity
• Science Center QED Proof-of-Concept Program
• Michelson Spark Grants COVID-19 Response Round (CLOSED-Announcement to awardees in coming weeks)
• Mozilla Open Source COVID-19-Related Technology Projects
• Amazon Web Services Diagnostic Development Initiative (DDI)  
• Google Cloud Research Credits

Additional Funding Opportunities (--Updated 6.4.2020)

• John Hopkins University-COVID Decision Making Initiative (CDMI)
• Deutsche Forschungsgemeinschaft (CLOSED)
• White House Office of Science and Technology Policy (OSTP)
• Medical CBRN Defense Consortium
• C-19 Work from Home Cybersecurity Grant (CLOSED)
• 2020 AARP Community Challenge (CLOSED)

Resources

• COGR: Institutitonal and Agency Responses to COVID-19 and Additional Resources (NEW 5.12.2020)
• IRB Guidance on Human Subjects Protections Considerations Related to COVID-19
• IACUC Guidance on Animal Care Related to COVID-19

Sponsor Guidance Related to COVID-19

Office of Management and Budget (Updated-- 7.23.2020)

• M-20-26, "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"
• M-20-17, “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations”
• M-20-11, "Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly impacted by the Novel Coronavirus (COVID-19)"

Defense Advanced Research Projects Agency

• Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers

National Institutes of Health

• NIH Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19
• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
• Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
• FAQs on COVID-19  Flexibilities for Applicants and Recipients
• NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
• General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
• NIH Guidance on Travel and Meetings Hosted by NIH
• NIH Extramural Response to Natural Disasters and Other Emergencies
• Special OLAW Webinar on March 19: Pandemic Contingency Planning and Its Impact on Animal Care

Department of Defense

•  CDMRP COVID-19 FAQs for Grant Applicants and Recipients

Department of Energy

• FAQ's for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19)
• March 2020 Memorandum; Accommodating Interruptions from Coronavirus Disease 2019

National Aeronautics and Space Administration : Assistant Administrator for Procurement Message on Coronavirus

National Science Foundation

• Proposal & Award Policies & Procedures Guide (NEW-4.2.2020)
• Additional Guidance on NSF's Implementation
• Impact on Existing Deadline Dates

U.S. Food and Drug Administration : Guidance on Clinical Trials